Accurate preoperative staging of gastric cancer and the assessment of tumor response to
neoadjuvant treatment is of importance for treatment and prognosis. Current imaging …

Identifying locoregional gastric cancer patients who are at high risk for relapse after
resection could facilitate early intervention. By detecting molecular residual disease (MRD) …

Gastrointestinal cancers, including oesophageal, gastric and colorectal cancers (CRC) have
high rates of disease recurrence despite curative resection. There are a number of recent …

Background Serum prealbumin (PALB) can predict the prognosis of patients with gastric
cancer (GC). However, the prognostic value of combination of C-reactive protein and PALB …

Background The definition and predictors of early recurrence (ER) for gastric cancer (GC)
patients after radical gastrectomy are unclear. Methods A minimum-p value approach was …

Introduction To assess the ability of the Age-Adjusted Charlson Comorbidity Index (ACCI) to
predict survival after radical gastrectomy in patients with gastric cancer (GC). Method Data …

Gastric adenocarcinoma (GAC) is a common cause of cancer-related death worldwide. GAC
can be classified as intestinal or diffuse. Intestinal-type cancers are common and reported to …

Background The rise in incidence and mortality of gastrointestinal mixed
adenoneuroendocrine carcinoma (MANEC) has not been well focused. The aim of our study …

Introduction Postoperative recurrence and metastasis of gastric cancer (GC) are primary
factors that contribute to poor prognosis. GC recurs at a rate of approximately 70%–80 …

Background and Objectives The optimal extent of lymphadenectomy in the treatment of
gastric adenocarcinoma is debated. We compared gastrectomy outcomes following limited …